[HTML][HTML] Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries

…, J Guiot, A Morais, S Clemente… - ERJ open …, 2022 - Eur Respiratory Soc
The PERSEIDS study aimed to estimate incidence/prevalence of interstitial lung diseases (ILDs),
fibrosing interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic …

[PDF][PDF] Estado e políticas sociais sobre a velhice em Portugal (1990-2008)

…, MH Santos, MI Santos, S Clemente - Análise Social, 2012 - repositorio.iscte-iul.pt
Partindo do princípio de que o Estado, através da implementação das políticas sociais de
velhice, tem contribuído fortemente para a institucionalização do problema social da velhice e …

[HTML][HTML] Whole transcription profile of responders to anti-TNF drugs in pediatric inflammatory bowel disease

…, FJ Eizaguirre, JA Blanca-García, S Clemente… - Pharmaceutics, 2021 - mdpi.com
Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not
respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify …

[HTML][HTML] Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

…, M Velasco, LM Palomino, S Clemente… - International Journal of …, 2023 - mdpi.com
The genetic polymorphisms rs2395185 and rs2097432 in HLA genes have been associated
with the response to anti-TNF treatment in inflammatory bowel disease (IBD). The aim was …

[HTML][HTML] Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

…, M Velasco, LM Palomino, S Clemente… - Pharmacological …, 2023 - Elsevier
Few genetic polymorphisms predict early response to anti-TNF drugs in inflammatory bowel
disease (IBD), and even fewer have been identified in the pediatric population. However, it …

Genetic predictors of long-term response to antitumor necrosis factor agents in pediatric inflammatory bowel disease

…, A Solar-Boga, O Segarra, S Clemente… - Journal of pediatric …, 2020 - journals.lww.com
Objectives: Inflammatory bowel disease (IBD) is more complex in children and they will have
to live with the disease for much longer. For this reason, it is necessary to optimize treatment…

Pharmacogenetics of trough serum anti‐TNF levels in paediatric inflammatory bowel disease

…, O Segarra, S Clemente… - British Journal of …, 2021 - Wiley Online Library
Aims Identifying DNA variants associated with trough serum anti‐tumour necrosis factor (TNF)
levels could predict response to treatment in inflammatory bowel disease (IBD). To date, …

[HTML][HTML] Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

…, M Velasco, LM Palomino, S Clemente… - Biomedicine & …, 2024 - Elsevier
Background/aims Changes in gene expression profiles among individuals with inflammatory
bowel diseases (IBDs) could potentially influence the responsiveness to anti-TNF treatment…

[PDF][PDF] Pandemic babies? Fertility in the aftermath of the first COVID-19 wave across European regions

…, C Bagavos, A Berrington, I Čipin, S Clemente… - 2022 - ssb.brage.unit.no
Early evidence demonstrates that the fertility response to the COVID-19 pandemic has varied
across European countries. Yet, prior research indicates that fertility responses to disasters …

Placental blood leukocytes are functional and phenotypically different than peripheral leukocytes during human labor

…, A Flores-Pliego, S Clemente-Galvan… - Journal of reproductive …, 2010 - Elsevier
Rupture of the fetal membranes during human labor is associated with an inflammatory
process localized to the maternal–fetal interface. There is evidence that specific leukocytes …